The prognostic value of telomerase expression in peripheral blood mononuclear cells of head and neck cancer patients

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 29, Issue 2, 2006, Pages 163-167

  Lee, Byung Joo ^a,b   Wang, Soo Geun ^a,b   Choi, Jin Sik ^a,b   Lee, Jin Choon ^a,b   Goh, Eui Kyung ^a,b   Kim, Myung Gu ^c  

^a Pusan National University School of Medicine   (South Korea)

^b Pusan National University   (South Korea)

^c Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Head and neck squamous cell carcinoma; Peripheral blood mononuclear cells; Prognosis; Telomerase

Indexed keywords

CISPLATIN; DOCETAXEL; TELOMERASE; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER SURVIVAL; FEMALE; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; HYPOPHARYNX CANCER; LARYNX CANCER; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; MULTIMODALITY CANCER THERAPY; NECK DISSECTION; OROPHARYNX CANCER; PERIPHERAL BLOOD MONONUCLEAR CELL; PROGNOSIS; TELOMERIC REPEAT AMPLIFICATION PROTOCOL; TREATMENT OUTCOME; BIOSYNTHESIS; CANCER STAGING; CULTURE TECHNIQUE; DISEASE COURSE; ENZYMOLOGY; GENE EXPRESSION PROFILING; GENETICS; HEAD AND NECK TUMOR; MIDDLE AGED; MONONUCLEAR CELL; PATHOLOGY; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; CELL CULTURE TECHNIQUES; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION PROFILING; HEAD AND NECK NEOPLASMS; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; SURVIVAL ANALYSIS; TELOMERASE; TUMOR MARKERS, BIOLOGICAL;

EID: 33645790125     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/01.coc.0000207372.64733.b0     Document Type: Article

References (24)

1. Blackburn EH. Structure and function of telomeres. Nature. 1991;350:569-573.
2. Harley CB. Telomere loss: mitotic clock or genetic time bomb? Mutat Res. 1991;256:271-282.
3. Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science. 1994;266:2011-2015.
4. Liao CT, Tung-Chieh Chang J, et al. Telomerase as an independent prognostic factor in head and neck squamous cell carcinoma. Head Neck. 2004;26:504-512.
5. Tatsumoto N, Hiyama E, Murakami Y, et al. High telomerase activity is an independent prognostic indicator of poor outcome in colorectal cancer. Clin Cancer Res. 2000;6:2696-2701.
6. Maruyama Y, Hanai H, Fujita M, et al. Telomerase length and telomerase activity in carcinogenesis of the stomach. Jpn J Clin Oncol. 1997;27:216-220.
7. Lee BK, Diebel E, Neukam FW, et al. Diagnostic and prognostic relevance of expression of human telomerase subunits in oral cancer. Int J Oncol. 2001;19:1063-1068.
8. Ries JC, Hassfurther E, Steininger H, et al. Correlation of telomerase activity, clinical prognosis and therapy in oral carcinogenesis. Anticancer Res. 2001;21:1057-1063.
9. Hiyama K, Hirai Y, Kyoizumi S, et al. . M. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol. 1995;155:3711-3715.
10. Ge P, Zhang B, Zhang J, et al. Telomerase activity of peripheral blood mononuclear cells from patients with laryngeal carcinoma. Am J Clin Oncol. 2004;27:191-194.
11. Sumida T, Sogawa K, Hamakawa H, et al. Detection of telomerase activity in oral lesions. J Oral Pathol Med. 1998;27:111-115.
12. Patel MM, Parekh LJ, Jha FP, et al. Clinical usefulness of telomerase activation and telomere length in head and neck cancer. Head Neck. 2002;24:1060-1067.
13. Taga S, Osaki T, Ohgami A, et al. Prognostic impact of telomerase activity in non-small cell lung cancers. Ann Surg. 1999;230:715-720.
14. Hiyama E, Hiyama K. Clinical utility of telomerase in cancer. Oncogene. 2002;21:643-649.
15. Yamada O, Motoji T, Mizoguchi H. Up-regulation of telomerase activity in human lymphocytes. Biochim Biophys Acta. 1996;1314:260-266.
16. Katayama Y, Kohriyama K. Telomerase activity in peripheral blood mononuclear cells of systemic connective tissue diseases. J Rheumatol. 2001;28:288-291.
17. Wu K, Volke A, Lund M, et al. Telomerase activity is spontaneously increased in lymphocytes from patients with atopic dermatitis and correlates with cellular proliferation. J Dermatol Sci. 1999;22:24-30.
18. Goh EK, Lee BJ, Wang SG, et al. Expression of telomerase activity in cholesteatoma otitis media. J Laryngol Otol. 2001;115:881-884.
19. Belair CD, Yeager TR, Lopez PM, et al. Telomerase activity: a biomarker of cell proliferation, not malignant transformation. Proc Natl Acad Sci USA. 1997;94:13677-13682.
20. Jain S, Filipe MI, Hall PA, et al. Prognostic value of proliferating cell nuclear antigen in gastric carcinoma. J Clin Pathol. 1991;44:655-659.
21. Dobros W, Rys J, Niezabitowski A, et al. The prognostic value of proliferating cell nuclear antigen (PCNA) in the advanced cancer of larynx. Auris Nasus Larynx. 1998;25:295-301.
22. Visakorpi T. Proliferative activity determined by DNA flow cytometry and proliferating cell nuclear antigen (PCNA) immunohistochemistry as a prognostic factor in prostatic carcinoma. J Pathol. 1992;168:7-13.
23. Soria JC, Gauthier LR, Raymond E. Molecular detection of telomerase-positive circulating epithelial cells in metastatic breast cancer patients. Clin Cancer Res. 1999;5:971-975.
24. Soria JC, Morat L, Durdux C, et al. The molecular detection of circulating tumor cells in bladder cancer using telomerase activity. J Urol. 2002;167:352-356.